Precision therapeutics for genetic forms of neurodegeneration

First-in-class foundational checkpoint immunotherapies

Discovering new medicines with ultra-throughput biochemistry and machine learning

Next-generation interventions to cure neurodegeneration and delay brain aging

Targeting pathogenic cells to treat aging and chronic diseases

Turning stem cells into human eggs to reimagine family planning

Regenerative and gene therapies to restore hearing and balance

Activation of the endogenous immune system for eliminating pathogenic cells

AI-led drug discovery engine translating conserved pathways of disease resistance across species

Next generation of induced proximity medicines

Pooled in vivo platform for new therapeutics tackling complex age-related disease

Healthspan and lifespan extension for dogs

Therapies for gastrointestinal and liver disease

Platform for therapeutics targeting mTORC1

Novel gene editing technology to develop new class of medicines

Therapeutics to heal the blood-brain barrier

Redefining human capabilities with advanced medical technology

Targeted therapies for bone regeneration to treat age-related bone loss

Developing the first human aging drugs

Therapeutics for body composition and cardiometabolic health

Restoring muscle function in aging and dystrophy

Developing therapies targeting gut-organ-axes to increase healthspan

Multiplex-editing therapies to target age-related disease

Therapeutics to slow, halt, or reverse diseases of aging

Cryopreservation technology for tissues and organs to end organ supply shortages